Back
Theravance Biopharma, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
TBPH
Theravance Biopharma, Inc.
Last Price:
$18.79
Seasonality Move:
0.09%
7 Day Trial
ALL ACCESS PASS
$
7
Theravance Biopharma, Inc. Stock Forecast
-
Over the next 52 weeks, Theravance Biopharma, Inc. has on average historically risen by 9% based on the past 11 years of stock performance.
-
Theravance Biopharma, Inc. has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
-
Is Theravance Biopharma, Inc. Stock Undervalued?The current Theravance Biopharma, Inc. [TBPH] share price is $18.79. The Score for TBPH is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
TBPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Theravance Biopharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Theravance Biopharma, Inc. has on average historically risen by 9% based on the past 11 years of stock performance.
Theravance Biopharma, Inc. Stock Rating
Sell
39
Theravance Biopharma, Inc. (TBPH)
is a Sell
Is Theravance Biopharma, Inc. overpriced?
-
Theravance Biopharma, Inc. has risen higher in 5 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 45.45%
Theravance Biopharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
theravance.com
52-Week Data
52-Week High:
20.33
52-Week Low:
7.90
Prediction Charts
Market Cap:
952.1M
Price in USD:
18.79
Volume:
1.2M
Beta:
0.72
Technical Analysis
SMA50:
16.59
SMA100:
15.02
SMA200:
12.50
52-Wk Change:
93.11%
Stock Predictions
-
Is Theravance Biopharma, Inc. stock public?Yes, Theravance Biopharma, Inc. is a publicly traded company.
-
What is the Theravance Biopharma, Inc. stock quote today?The Theravance Biopharma, Inc. stock price is 18.79 USD today.
-
How to buy Theravance Biopharma, Inc. stock online?You can buy Theravance Biopharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 19.67 | 18.43 | 19.74 | 18.39 |
| Dec-3 | 18.75 | 18.89 | 19.13 | 18.50 |
| Dec-4 | 19.11 | 18.70 | 19.11 | 18.59 |
| Dec-5 | 18.73 | 18.55 | 18.85 | 18.48 |
| Dec-8 | 18.70 | 18.12 | 18.85 | 18.03 |
| Dec-9 | 18.25 | 17.81 | 18.44 | 17.76 |
| Dec-10 | 17.85 | 17.61 | 17.88 | 17.25 |
| Dec-11 | 17.72 | 17.68 | 17.92 | 17.26 |
| Dec-12 | 17.72 | 18.17 | 18.34 | 17.48 |
| Dec-15 | 18.28 | 17.77 | 18.36 | 17.70 |
| Dec-16 | 17.68 | 17.53 | 17.96 | 17.46 |
| Dec-17 | 17.55 | 17.91 | 18.39 | 17.25 |
| Dec-18 | 18.00 | 18.18 | 18.60 | 17.80 |
| Dec-19 | 18.38 | 18.79 | 18.80 | 18.02 |
Theravance Biopharma, Inc. Earnings
Theravance Biopharma, Inc. Earnings Report: Per Share Theravance Biopharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Theravance Biopharma, Inc. Forecast Revenue Growth
Theravance Biopharma, Inc. Stock Analysis: Historical quarterly revenues per share for Theravance Biopharma, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and a decrease next year of $0.18 per share.
* Theravance Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.